[14] Rocca CJ， Ur SN， Harrison F and Cherqui S. rAAV9 combined with renal vein injection is optimal for kidney-targeted gene delivery： conclusion of a comparative study. Gene Ther，2014，21(6)：618-628.

    [15] Tian F， Wang L， Arias A， Yang M， Sharifi BG and Shah PK. Comparative antiatherogenic effects of intravenous AAV8- and AAV2-mediated ApoA-IMilano gene transfer in hypercholesterolemic mice. J Cardiovasc Pharmacol Ther ......